Disease

Human Papillomavirus

University of Phoenix

HCS/330

April 17, 2011

Pamela Orr, RN, BSN, MsPH

Human Papillomavirus

David J Hutchinson and Kristin C Klein wrote a journal article about the Human Papillomavirus. They both have an extensive background in pharmacy. Human papillomavirus is the most common sexually transmitted disease. There are two types of vaccines, quadrivalent and bivalent. Both of the vaccines are to prevent women from getting HPV 6, 11, 16, and 18. Bivalent prevent all of these as long as they are not associated with genital warts. The vaccine must be taken in three doses in order for it to work correctly. People tend to think giving this vaccine to girls between 11 and 12 is too young. It has caused some controversy.

David J Hutchinson and Kristin C Klein

David J Hutchinson is an Assistant Professor of Pharmacy Practice, Wegmans School of Pharmacy at St John Fischer College in Rochester, New York. David was a Pediatrics Specialty Resident and Clinical Instructor at the University of Michigan Hospitals and Health Centers (UMHHC). Kristin C Klein is a Clinical Pharmacist, Pediatric Infectious Diseases, and Clinical Assistant Professor. She also has Pharmacy Services and College of Pharmacy at University of Michigan Hospitals and Health Centers.

Human Papillomavirus Disease

The article is about the human papillomavirus and the vaccine for it. Human papillomavirus is known to be the most common sexual transmitted disease. Sexually active younger men and women are the greatest risk getting human papillomavirus. 90% of people infected with human papillomavirus are usually clear within two years. Some younger people infected with the disease are usually clear within a year. The risk factors of HPV are sexual behavior, the number of sexual partners, the partner’s sexual history, and a person’s age. Even though most HPV infections are cleared without doctor visits, the infections are linked with the development of cervical cancer in...